• 13 July 2010: Excellent Additional VitroGro Clinical Results & Completion of Commercial Scale Manufacturing [PDF]
• 17 Jun 2010: More Exceptional Clinical Results for VitroGro [PDF]
• 31 May 2010: Interview with Dr. Steve Mercer, CEO & Director [Video]
• 16 Mar 2010: Investor Newsletter [PDF]
• 7 Jan 2010: Human Trial of VitroGro: Prof Keith Harding, Cardiff University [PDF]

• 22 Dec 2009: Appendix 3Y Change in Directors Interest Notice [PDF]
• 15 Dec 2009: Notice of Change of Interests of Substantial Shareholder 2 [PDF]
• 15 Dec 2009: Notice of Change of Interests of Substantial Shareholder [PDF]
• 15 Dec 2009: Appendix 3Y Change in Directors Interest Notice 2 [PDF]
• 15 Dec 2009: Appendix 3Y Change in Directors Interest Notice [PDF]
• 14 Dec 2009: Change of Share Registry Address [PDF]
• 11 Dec 2009: Appendix 3B and Cleansing Notice after SPP [PDF]
• 7 Dec 2009: Share Purchase Plan Closes Oversubscribed [PDF]
• 27 Nov 2009: Resolutions Passed at 2009 AGM [PDF]
• 27 Nov 2009: CEO AGM Presentation [PDF]
• 27 Nov 2009: Chairman’s 2009 AGM Address [PDF]
• 26 Nov 2009: Second Core VitroGro® Patent Granted in Australia [PDF]
• 25 Nov 2009: Second VitroGro Patent Allowed in USA [PDF]
• 23 Nov 2009: Shareholder Newsletter [PDF]
• 23 Nov 2009: Excellent VitroGro Results: Australian Human Trial [PDF]
• 18 Nov 2009: Outstanding Human Trial Results for VitroGro® [PDF]
• 29 Oct 2009: Appendix 4C Quarterly Report [PDF]
• 21 Oct 2009: Notice of Tissue Therapies AGM [PDF]
• 21 Oct 2009: Share Purchase Plan Letter to Ineligible Share Holders [PDF]
• 21 Oct 2009: Share Purchase Plan Letter to Option Holders [PDF]
• 21 Oct 2009: Share Purchase Plan [PDF]
• 21 Oct 2009: Share Purchase Plan Letter to Shareholders [PDF]
• 21 Oct 2009: Announcement of Share Purchase Plan [PDF]
• 19 Oct 2009: Appendix 3B Following Placement [PDF]
• 19 Oct 2009: s708A(5)(e) Disclosure Notice Issue of Placement Shares [PDF]
• 19 Oct 2009: Tissue Therapies Successful $5 million Capital Raising [PDF]
• 15 Oct 2009 : Trading Halt [PDF]
• 08 Oct 2009: 2009 Annual Report [PDF]
• 20 Aug 2009: Change of Share Registry Address [PDF]
• 20 Aug 2009: Appendix 3X Initial Directors Interest [PDF]
• 04 Aug 2009: Appendix 4E Preliminary Final Report [PDF]
• 03 Aug 2009: Tissue Therapies Lists on Frankfurt Stock Exchange [PDF]
• 29 Jul 2009: Appendix 4C Quarterly Report [PDF]
• 23 Jul 2009: Excellent Preclinical Results for New Formulation VitroGro® & Progressive Human Trial Results [PDF]
• 10 Jul 2009: Tissue Therapies Wins Smart State Grant for Single Protein VitroGro® [PDF]
• 01 Jul 2009: More VitroGro® Patents Granted in South Korea and Australia [PDF]
• 30 Jun 2009: Appointment of Dr Cherrell Hirst as Company Director [PDF]
• 29 Apr 2009: Results of 2nd Patient in Canadian Clinical Trial [PDF]
• 29 Apr 2009: Appendix 4C Quarterly Report [PDF]
• 30 Mar 2009: Notice of Change of Interests of Substantial Shareholder [PDF]
• 14 Apr 2009: Resignation of Prof David Gardiner as Director [PDF]
• 19 Mar 2009: Appendix 3B QUT Note Conversion [PDF]
• 13 Mar 2009: Appoint Mel Bridges Director [PDF]
• 12 Mar 2009: App3Y Form 604 Options after Rights Issue [PDF]
• 10 Mar 2009: Further Investment in Tissue Therapies [PDF]
• 05 Mar 2009: Asia Union Change of Interests Subst. Shareholder Form 604 [PDF]
• 05 Mar 2009: App 3B & Top 20 [PDF]
• 04 Mar 2009: Rights Issue Completion [PDF]
• 27 Feb 2009: App4D Dir Report Indep Dec FINAL [PDF]
• 13 Feb 2009: Rights Issue Prospectus despatched [PDF]
• 03 Feb 2009: Supp Prospectus Jan 2009 [PDF]
• 02 Feb 2009: Notice of Initial Substantial Shareholder [PDF]
• 02 Feb 2009: 29% Healing of Chronic Ulcer in 6 weeks: 1st Patient in Canadian Trial [PDF]
• 30 Jan 2009: 2nd South African Patent Granted [PDF]
• 28 Jan 2009: Appendix 4C Quarterly Report [PDF]
• 28 Jan 2009: Tissue Therapies Prospectus
• 28 Jan 2009: Appendix 3B New Issue Announcement [PDF]
• 28 Jan 2009: Non-Renounceable Rights Issue [PDF]
• 28 Jan 2009: Non-Renounceable Rights Issue-Option Holder participation [PDF]
• 28 Jan 2009: Non-Renounceable Rights Issue-Overseas Shareholders [PDF]
• 19 Jan 2009: Results of VitroGro Venous Ulcer Human Trial [PDF]
• 13 Jan 2009: US Patent Granted [PDF]
• 12 Jan 2009: Appendix 3B CEO Options [PDF]
• 09 Jan 2009: App 3B Issue New Shares [PDF]

• 27 Nov 2008: AGM CEO Presentation [PDF]
• 27 Nov 2008: AGM Chairman's Address [PDF]
• 27 Nov 2008: AGM Chief Scientist Presentation [PDF]
• 27 Nov 2008: AGM Resolutions passed with Proxy [PDF]
• 11 Nov 2008: Clinical Results Patient 3 [PDF]
• 11 Nov 2008: Clinical Results Patient 4 [PDF]
• 11 Nov 2008: Health Canada Approval [PDF]
• 31 Oct 2008: Appendix 4C Quarterly Report [PDF]
• 27 Oct 2008: 2008 Annual Report [PDF]
• 27 Oct 2008: Notice of Meeting Proxy Form [PDF]
• 20 Oct 2008: Results of Second Patient Treated with VitroGro® [PDF]
• 22 Sep 2008: Change of CEO Interest [PDF]
• 03 Sep 2008: Results of First Patient Treated with VitroGro® [PDF]
• 19 Aug 2008: SPP Extended [PDF]
• 19 Aug 2008: SPP Extended Timetable [PDF]
• 06 Aug 2008: SPP docs issued to shareholders [PDF]
• 11 Aug 2008: Perth Human Trials [PDF]
• 08 Aug 2008: Appendix 4E [PDF]
• 23 Jul 2008: Correction to Link contact details [PDF]
• 21 Jul 2008: Share Purchase Plan Rules [PDF]
• 21 Jul 2008: Letter to Shareholders - Share Purchase Plan [PDF]
• 21 Jul 2008: Letter to Optionholders [PDF]
• 21 Jul 2008: Investor Update [PDF]
• 21 Jul 2008: Existence of Share Purchase Plan [PDF]
• 21 Jul 2008: Appendix 3B [PDF]
• 09 Jul 2008: Clinical Wound Study [PDF]
• 29 Apr 2008: Appendix 4C Quarterly Report [PDF]
• 23 Apr 2008: Further Positive VitroGro® Preclinical Results & Clinical Trial Update [PDF]
• 11 Mar 2008: Change of CEO and Chief Scientist Interest [PDF]
• 07 Feb 2008: VitroGro® Human Clinical Trial Ethics Approval Granted [PDF]
• 07 Feb 2008: Appendix 4D [PDF]
• 31 Jan 2008: Appendix 4C Quarterly Report [PDF]
• 16 Jan 2008: Convertible Note Loan Facility Agreement [PDF]
• 14 Jan 2008: Investor Newsletter [PDF]

• 06 Dec 2007: Appendix 3Y [PDF]
• 06 Dec 2007: Appendix 3Y [PDF]
• 29 Nov 2007: Appendix 3B [PDF]
• 27 Nov 2007: Appendix 3Y [PDF]
• 30 Oct 2007: Appendix 4C Quarterly Report [PDF]
• 18 Oct 2007: New VitroGro® Formulation & Patent Applications [PDF]
• 18 Oct 2007: Chairman's AGM Address [PDF]
• 18 Oct 2007: Resolutions Passed at Annual General Meeting [PDF]
• 18 Sep 2007: VitroGro® Clinical Trial and Commercial Update [PDF]
• 18 Sep 2007: Annual Report [PDF]
• 18 Sep 2007: Notice of Annual General Meeting/Proxy Form [PDF]
• 30 Aug 2007: Equity Option Plan - Options Issued to Key Researchers & Contractors [PDF]
• 16 Aug 2007: Investor Newsletter [PDF]
• 09 Aug 2007: Tissue Therapies' Full-Year Results to 30 June 2007 [PDF]
• 30 Jul 2007: Appendix 4C Quarterly Report [PDF]
• 26 Jul 2007: Strengthened Financial Position for VitroGro® Human Trials [PDF]
• 26 Jul 2007: Section 708 Disclosure Notice [PDF]
• 26 Jul 2007: Appendix 3B [PDF]
• 09 Jul 2007: CEO Swaps Cash Bonus for Options [PDF]
• 28 Jun 2007: Change of Interests of Substantial Holders [PDF]
• 20 Jun 2007: VitroGro Gets Positive News from Health Canada [PDF]
• 15 Jun 2007: Global Wound Care Expert to Advise Tissue Therapies [PDF]
• 23 May 2007: Awarded Australian Research Council Grant [PDF]
• 22 May 2007: VitroGro Human Trials to Accelerate Commercialisation [PDF]
• 08 May 2007: Awarded Queensland Government Grant for Stem Cell Project [PDF]
• 04 May 2007: Awarded $1.9 Million P3 Grant [PDF]
• 23 Apr 2007: Change of Substantial Holding [PDF]
• 20 Apr 2007: Appendix 4C Quarterly Report [PDF]
• 19 Apr 2007: Notice of Initial Substantial Shareholder [PDF]
• 17 Apr 2007: Tissue Therapies Announces Rights Issue Reporting [PDF]
• 10 Apr 2007: Notification of Change of Registered Office [PDF]
• 05 Apr 2007: Tissue Therapies Announces Completion of Rights Issue [PDF]
• 16 Mar 2007: Joint Development Agreement Signed with Novozymes [PDF]
• 14 Mar 2007: Tissue Therapies Despatches Prospectus Today [PDF]
• 06 Mar 2007: South African Patent Granted [PDF]
• 28 Feb 2007: Rights Issue Prospectus [PDF]
• 28 Feb 2007: Letter to Shareholders Aus NZ re Rights Issue [PDF]
• 08 Feb 2007: Half Yearly Report & Half Year Accounts [PDF]
• 30 Jan 2007: Commitments Test Entity - Second Quarter Report [PDF]
• 29 Jan 2007: World Wide Exclusive Laboratory Supply Contract Signed with Invitrogen [PDF]

• 30 Nov 2006: Positive VitroGro® Preclinical Dose Study Results [PDF]
• 14 Nov 2006: Appendix 3X [PDF]
• 14 Nov 2006: Donald Home Appointed Non-Executive Director [PDF]
• 09 Nov 2006: Chairman's AGM Address [PDF]
• 09 Nov 2006: AGM Presentation [PDF]
• 19 Oct 2006: Commitments Test Entity - First Quarter Report [PDF]
• 06 Oct 2006: Notice of AGM 2006 [PDF]
• 06 Oct 2006: Annual Report 2006 [PDF]
• 24 Aug 2006: VitroGro® Preclinical Dose Study Starts [PDF]
• 22 Aug 2006: Major Breakthrough - VitroGro® Reduced to Three Proteins in One [PDF]
• 03 Aug 2006: Preliminary Final Report [PDF]
• 21 Jul 2006: Commitments Test Entity - Fourth Quarter Report [PDF]
• 30 May 2006: VitroGro World-First - Culture of Human Embryonic Stem Cells [PDF]
• 29 May 2006: Tissue Therapies Investor Newsletter [PDF]
• 12 May 2006: CEO appointed as Director [PDF]
• 21 Apr 2006: Appendix 3B [PDF]
• 21 Apr 2006: Commitments Test Entity - Third Quarter Report [PDF]
• 12 Apr 2006: Tissue Therapies Chief Scientist Wins Senior Fellowship [PDF]
• 23 Mar 2006: Appendix 3B [PDF]
• 22 Mar 2006: VitroGro component supply contract signed [PDF]
• 21 Mar 2006: NZ Patent Accepted [PDF]
• 10 Mar 2006: Appendix 3B & Media Release (Options Issued to CEO) [PDF]
• 08 Mar 2006: Restricted shares & options being released from escrow [PDF]
• 09 Feb 2006: Half Year Results to December 2005 [PDF]
• 09 Feb 2006: Half Yearly Report & Accounts to 31 December 2005 [PDF]
• 27 Jan 2006: VitroGro Dosage Date for Human Trials [PDF]
• 25 Jan 2006: Commitments Test Entity - Second Quarter Report [PDF]
• 24 Jan 2006: BGN: Commences 2006 with additional contracts [PDF]

• 22 Dec 2005: Completion of Share Purchase Plan [PDF]
• 22 Dec 2005: Appendix 3B [PDF]
• 22 Dec 2005: Share Purchase Plan Completed [PDF]
• 24 Nov 2005: Section 708A(6) Notice - Issue of Placement Shares [PDF]
• 22 Nov 2005: Appendix 3B [PDF]
• 17 Nov 2005: Share Placement & Share Purchase Plan [PDF]
• 16 Nov 2005: Offer of Placement Shares [PDF]
• 16 Nov 2005: Trading Halt [PDF]
• 11 Nov 2005: Results of Meeting [PDF]
• 11 Nov 2005: Results of AGM [PDF]
• 11 Nov 2005: AGM Comments & CEO Presentation [PDF]
• 11 Nov 2005: Chairman's Address for 2005 AGM [PDF]
• 08 Nov 2005: Human Live Skin Model Developed [PDF]
• 26 Oct 2005: Major Product Milestone Achieved - Synthetic VitroGro [PDF]
• 21 Oct 2005: Commitments Test Entity - First Quarter Report [PDF]
• 12 Oct 2005: Notice of Annual General Meeting [PDF]
• 04 Oct 2005: VitroGro product milestone achieved [PDF]
• 30 Sep 2005: Annual Report [PDF]
• 11 Aug 2005: TIS Media Release and Appendix 4E for 30Jun05 [PDF]
• 19 Jul 2005: Commitments Test Entity - Fourth Quarter Report [PDF]
• 05 Jul 2005: VitroGro Potential confirmed for Healing Diabetic Ulcers [PDF]
• 31 May 2005: Australian Patent Accepted [PDF]
• 27 May 2005: Shareholder Update [PDF]
• 21 Apr 2005: Commitments Test Entity - Third Quarter Report [PDF]
• 15 Apr 2005: TIS Investor Newsletter April 2005 [PDF]
• 14 Apr 2005: Revised Appendix 3B [PDF]
• 14 Apr 2005: Equity Optn Pln-Optns Issued to Key Researchers/Contractors [PDF]
• 14 Apr 2005: Appendix 3B [PDF]
• 23 Mar 2005: A Winner in VitroGro Trials-Additional Information [PDF]
• 22 Mar 2005: Tissue Therapies A Winner in VitroGro Trials [PDF]
• 22 Mar 2005: Trading Halt [PDF]
• 01 Mar 2005: NZ Patent Granted & Timing of Animal Trial Results [PDF]
• 25 Feb 2005: Directors Report with Auditors Independence Declaration [PDF]
• 10 Feb 2005: Tissue Therapies Half-yearly Results to December 2004 [PDF]
• 10 Feb 2005: Half Yearly Report [PDF]
• 21 Jan 2005: Commitments Test Entity - Second Quarter Report [PDF]

• 21 Dec 2004: Initial VitroGro Animal Trials Completed [PDF]
• 16 Nov 2004: Results of AGM [PDF]
• 16 Nov 2004: AGM Presentation [PDF]
• 16 Nov 2004: Chairman's Address to Shareholders [PDF]
• 16 Nov 2004: To Develop Skin Models to Replace Animal Testing [PDF]
• 22 Oct 2004: Commitments Test Entity - First Quarter Report [PDF]
• 19 Oct 2004: Appendix 3B - Working Capital [PDF]
• 18 Oct 2004: Notice of Annual General Meeting [PDF]
• 12 Oct 2004: Strengthens Financial Resources [PDF]
• 11 Oct 2004: Trading Halt [PDF]
• 06 Oct 2004: Market Update Presentation by New CEO [PDF]
• 05 Oct 2004: QUT Advertising & Tissue Therapies [PDF]
• 28 Sep 2004: Annual Report [PDF]
• 27 Sep 2004: Commencement of CEO [PDF]
• 15 Sep 2004: Animal Trials Commence Using VitroGro [PDF]
• 13 Sep 2004: Appoints Chief Executive [PDF]
• 09 Sep 2004: Skin Research Project Presentation [PDF]
• 09 Sep 2004: Tissue BioRegenration & Integration Presentation [PDF]
• 09 Sep 2004: Confirmation of VitroGro Potential as Burns Treatment [PDF]
• 20 Aug 2004: 2004 Results [PDF]
• 20 Aug 2004: Preliminary Final Report [PDF]
• 17 Aug 2004: Chief Scientist Wins Smart Award [PDF]
• 22 Jul 2004: Commitments Test Entity - Fourth Quarter Report [PDF]
• 21 Jul 2004: Presentation [PDF]
• 21 Jul 2004: TIS & QIMR collaboration targets cancer [PDF]
• 14 Jul 2004: Presentation to World Union of Wound Healing Societies Mtg. [PDF]
• 08 Jun 2004: Leading Burns Surgeon to Conduct Trials Using VitroGro [PDF]
• 16 Apr 2004: VitroGro to be Showcased at Int. Growth Factors Conference [PDF]
• 15 Apr 2004: Commitments Test Entity - Third Quarter Report [PDF]
• 05 Apr 2004: First USA Sale [PDF]
• 19 Mar 2004: Appendix 3B - New Issue/Appendix 3X x4 [PDF]
• 18 Mar 2004: Restricted Securities [PDF]
• 18 Mar 2004: Pre-Quotation Disclosure [PDF]
• 18 Mar 2004: Distribution Schedule [PDF]
• 18 Mar 2004: Top 20 shareholders [PDF]
• 18 Mar 2004: Equity Option Plan [PDF]
• 17 Mar 2004: Admission to Official List [PDF]
• 03 Mar 2004: Disclosure Document [PDF]

Enquiries can be directed to investor@tissuetherapies.com.